Evolv Technology Reports Strong First Quarter Financial Results

Rhea-AI Summary

Evolv Technology (NASDAQ: EVLV) reported Q1 2022 revenue of $8.7 million, reflecting a 118% increase year-over-year. The company's Annual Recurring Revenue (ARR) reached $16.6 million, up 207% from the previous year. Evolv Express subscriptions grew by 227% to 910. Despite the growth, the company recorded a net loss of $14.6 million or ($0.10) per share. The firm reaffirmed its 2022 revenue outlook of $29-$31 million and adjusted EBITDA expectation of ($65-$67 million.

Positive

• Q1 revenue increased 118% to $8.7 million.
• Annual Recurring Revenue (ARR) rose 207% to $16.6 million.
• Total Contract Value (TCV) booked increased 128% to $19.2 million.

Negative

• Net loss widened to $14.6 million, compared to a loss of $13.8 million in Q1 2021.
• Adjusted EBITDA loss increased to $18.2 million from $7.6 million year-over-year.

– Company Reaffirms Outlook for 2022 – 

• Q1 Revenue of $8.7 million, up 118% year-over-year
• Q1 Ending ARR of $16.6 million, up 207% year-over-year
• Q1 Ending Evolv Express® subscriptions of 910, up 227% year-over-year

WALTHAM, Mass.--(BUSINESS WIRE)-- Evolv Technology (NASDAQ: EVLV), a global leader in weapons detection security screening, today announced financial results for its first quarter ended March 31, 2022 and reaffirmed its business outlook for 2022.

“We’re pleased to report solid first quarter results which were highlighted by strong growth in revenues, new customers and Evolv Express subscribers,” said Peter George, President and Chief Executive Officer of Evolv Technology. “Our results continue to reflect our expanding leadership position in North America as more facility operators adopt our solutions to digitally transform their security operations. Looking ahead, we believe we remain well positioned to execute on our strategic growth plans.”

Results for the First Quarter of 2022
Total revenue for the first quarter of 2022 was $8.7 million, an increase of 118% compared to $4.0 million for the first quarter of 2021. Total Contract Value (“TCV”)¹ of orders booked for the first quarter of 2022 was $19.2 million, an increase of 128% compared to $8.4 million in the first quarter of 2021. Annual Recurring Revenue (“ARR”)² was $16.6 million at the end of first quarter of 2022, an increase of 207% compared to $5.4 million in the first quarter of 2021. Net loss for the first quarter of 2022 was ($14.6) million, or ($0.10) per basic and diluted share, compared to net loss of ($13.8) million, or ($1.32) per basic and diluted share, for the first quarter of 2021. Adjusted earnings (loss)³ for the first quarter of 2022 was ($19.1) million, or ($0.13) per basic and diluted share, compared to ($10.5) million, or ($1.01) per basic and diluted share, for the first quarter of 2021. Adjusted EBITDA³ for the first quarter of 2022 was ($18.2) million, compared to ($7.6) million for the first quarter of 2021. As of March 31, 2022, the Company had cash and cash equivalents of $270.9 million compared to $307.5 million as of December 31, 2021.

Company Reaffirms Outlook for 2022
The Company today commented on its business outlook for 2022. The Company's outlook is based on the current indications for its business, which may change at any time.

	2022 Business Outlook
Estimate (In millions)	Issued March 14, 2022	Issued May 11, 2022
Total Revenue	$29-$31	No change
Annual Recurring Revenue2 (ARR) at 12/31	$27-$28	No change
Adjusted EBITDA3	($65-$67)	No change
Cash and Cash Equivalents	$220-$230	No change

Company to Host Live Conference Call and Webcast
The Company’s management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management’s outlook for the business and other matters. The conference call may be accessed in the United States by dialing +1.877.692.8955 and using access code 774298. The conference call may be accessed outside of the United States by dialing +1.234.720.6979 and using the same access code. The conference call will be simultaneously webcast on the Company’s investor relations website, which can be accessed at http://ir.evolvtechnology.com. A replay of the conference call will be available for a period of 30 days by dialing +1.866.207.1041 or +1.402.970.0847 and using access code 5434851 or by accessing the webcast replay on the Company’s investor relations website at http://ir.evolvtechnology.com.

About Evolv Technology
Evolv Technology (NASDAQ: EVLV) is a global leader in weapons detection security screening. Our mission is Evolv Technology (NASDAQ: EVLV) is a leader in weapons detection for security screening, securing the world’s most iconic venues and companies. Its mission is enabling a better experience and better security for venues, creating a safer world to work, learn, and play by transforming physical security to make everywhere safer. It gives sports fans, theme park visitors, concertgoers, shoppers, employees, students, and others peace of mind so that they can gather without fear of violence. Its security screening has scanned more than 250 million people, second only to the Department of Homeland Security’s Transportation Security Administration (TSA) in the United States, and its technology combines powerful, advanced sensors with proven artificial intelligence (AI), security ecosystem integrations, and comprehensive venue analytics to reliably detect threats 10 times faster than traditional metal detectors. Evolv Technology, Evolv Express®, Evolv Insights™, and Evolv Cortex AI™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit https://evolvtechnology.com.

¹ We define Total Contract Value, or TCV, of orders booked as the total value of the contract over the specified term. Our calculation of TCV is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases). TCV should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of TCV may differ from similarly titled metrics presented by other companies.

² We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

³ Non-GAAP Financial Measures In this press release, the Company’s adjusted gross profit, adjusted gross margin, adjusted EBITDA and adjusted earnings (loss) are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude one-time items which management believes provides a more meaningful representation of contribution margin. Adjusted EBITDA is defined as net income (loss) plus depreciation and amortization, share-based compensation, and certain other one-time expenses. Adjusted earnings (loss) is defined as net income (loss) plus stock-based compensation, change in fair value of derivative liability, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, change in fair value of common stock warrant liability, restructuring expenses, loss on impairment of lease equipment, and certain other one-time expenses. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operational performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided in this press release.

Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking” statements and information, within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events including but not limited to statements regarding our ability to meet our business outlook for revenue and profitability. Forward-looking statements involve the Company’s current expectations and projections relating to its financial condition, competitive position, future financial results, plans, objectives, and business. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “should,” “could,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or the negative of these terms or other similar expressions. These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect the Company’s current views with respect to future events and the Company’s performance and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Company’s history of losses and lack of profitability; the Company’s reliance on third party contract manufacturing; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the ability for the Company to obtain, maintain, protect and enforce the Company’s intellectual property rights; the concentration of the Company’s revenues on a single solution; the Company’s ability to timely design, produce and launch its solutions, the Company’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company’s securities; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risk that the COVID-19 pandemic, including variants, vaccine roll-out efforts, and local, state, and federal responses to addressing the pandemic may have an adverse effect on the Company’s business operations, as well as the Company’s financial condition and results of operations; litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources; and the risk factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission on March 28, 2022.

These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

EVOLV TECHNOLOGY CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (In thousands, except share and per share data) (Unaudited)
	Three Months Ended March 31,
		2022				2021
Revenue:
Product revenue	$	5,194			$	2,502
Subscription revenue		3,020				1,300
Service revenue		501				197
Total revenue		8,715				3,999
Cost of revenue:
Cost of product revenue		5,576				2,229
Cost of subscription revenue		1,065				595
Cost of service revenue		448				127
Total cost of revenue		7,089				2,951
Gross profit		1,626				1,048
Operating expenses:
Research and development		4,286				3,612
Sales and marketing		12,053				3,684
General and administrative		11,093				2,899
Loss from impairment of property and equipment		96				-
Total operating expenses		27,528				10,195
Loss from operations		(25,902	)			(9,147	)
Interest expense		(142	)			(2,447	)
Interest income		209				-
Change in fair value of derivative liability		—				(1,425	)
Change in fair value of contingent earn-out liability		4,226				-
Change in fair value of contingently issuable common stock liability		1,472				-
Change in fair value of public warrant liability		5,586				-
Change in fair value of common stock warrant liability		—				(736	)
Total other income (expense)	$	11,351			$	(4,608	)
Net loss and comprehensive loss – basic and diluted	$	(14,551	)		$	(13,755	)
Net loss per share – basic and diluted	$	(0.10	)		$	(1.32	)
Weighted average common shares outstanding – basic and diluted		142,878,406				10,443,323

EVOLV TECHNOLOGY CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share data) (Unaudited)
	March 31, 2022				December 31, 2021
Assets
Current assets:
Cash and cash equivalents	$	270,872			$	307,492
Restricted cash		400				400
Accounts receivable, net		8,589				6,477
Inventory		7,181				5,140
Current portion of contract assets		1,448				1,459
Current portion of commission asset		1,477				1,645
Prepaid expenses and other current assets		17,252				11,047
Total current assets		307,219				333,660
Restricted cash, noncurrent		275				275
Contract assets, noncurrent		3,321				3,418
Commission asset, noncurrent		4,239				3,719
Property and equipment, net		25,282				21,592
Operating lease right-of-use assets		2,287				-
Other assets		1,275				401
Total assets	$	343,898			$	363,065
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	4,645			$	6,363
Accrued expenses and other current liabilities		7,118				9,183
Current portion of deferred revenue		7,433				6,690
Current portion of deferred rent		—				135
Current portion of long-term debt		3,000				2,000
Current portion of operating lease liabilities		1,089				—
Total current liabilities		23,285				24,371
Deferred revenue, noncurrent		4,517				2,475
Deferred rent, noncurrent		—				333
Long-term debt, noncurrent		6,950				7,945
Operating lease liabilities, noncurrent		1,634				—
Contingent earn-out liability		18,128				20,809
Contingently issuable common stock liability		3,792				5,264
Public warrant liability		5,444				11,030
Total liabilities		63,750				72,227
Stockholders’ Equity:
Preferred stock		-				-
Common stock		14				14
Additional paid-in capital		399,424				395,563
Accumulated deficit		(119,290	)			(104,739	)
Total stockholders’ equity		280,148				290,838
Total liabilities and stockholders’ equity	$	343,898			$	363,065

EVOLV TECHNOLOGY CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited)
	Three Months Ended March 31,
		2022				2021
Cash flows from operating activities:
Net loss	$	(14,551	)		$	(13,755	)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		948				452
Write off of inventory		324				—
Adjustment to property and equipment for sales type leases		(321	)			—
Loss from impairment of property and equipment		96				—
Stock-based compensation		5,190				1,082
Noncash interest expense		5				2,344
Noncash lease expense		197				—
Provision recorded for allowance for doubtful accounts		—				(63	)
Change in fair value of derivative liability		—				1,425
Change in fair value of common stock warrant liability		—				736
Change in fair value of earn-out liability		(4,226	)			—
Change in fair value of contingently issuable common stock		(1,472	)			—
Change in fair value of public warrant liability		(5,586	)			—
Changes in operating assets and liabilities
Accounts receivable		(2,112	)			(874	)
Inventory		(6,985	)			(433	)
Commission assets		(351	)			(391	)
Contract assets		108				(119	)
Prepaid expenses and other current assets		(5,280	)			(4,104	)
Accounts payable		(1,867	)			1,194
Deferred revenue		2,778				(621	)
Deferred rent		(468	)			(11	)
Accrued expenses and other current liabilities		(2,065	)			1,100
Operating lease liabilities		(229	)			—
Net cash used in operating activities		(35,867	)			(12,038	)
Cash flows from investing activities:
Development of internal-use software		(646	)			-
Purchases of property and equipment		(323	)			(2,522	)
Net cash used in investing activities		(969	)			(2,522	)
Cash flows from financing activities:
Proceeds from exercise of stock options		216				455
Repayment of financing obligations		-				(359	)
Proceeds from long-term debt, net of issuance costs		-				31,882
Net cash provided by financing activities		216				31,978
Net increase (decrease) in Cash, cash equivalents and restricted cash		(36,620	)			17,418
Cash, cash equivalents and restricted cash, beginning of period		308,167				4,704
Cash, cash equivalents and restricted cash, end of period	$	271,547			$	22,122

EVOLV TECHNOLOGY RECONCILIATION OF FORECASTED 2022 NET LOSS TO ADJUSTED EBITDA (In thousands) (Unaudited)
	Twelve Months Ended December 31, 2022
	High				Low
Net income (loss)	$	(83,000	)		$	(85,000	)
Adjustments to reconcile net income (loss) to Adjusted EBITDA:
Depreciation and amortization		6,000				6,000
Stock-based compensation		11,000				11,000
Other expense		1,000				1,000
Adjusted EBITDA	$	(65,000	)		$	(67,000	)

EVOLV TECHNOLOGY SUMMARY OF KEY OPERATING STATISTICS (Unaudited)
($ in thousands)	December 31, 2020	March 31, 2021	June 30, 2021	September 30, 2021	December 31, 2021	March 31, 2022
New customers	6	13	21	23	27	44
Total contract value of orders booked	$5,956	$8,424	$10,476	$16,995	$17,916	$19,167
Annual recurring revenue	$4,034	$5,424	$7,423	$9,932	$12,907	$16,641
Remaining performance obligation	$13,381	$17,658	$24,930	$34,152	$40,160	$50,537
Contract value for units in backlog	n/a	n/a	n/a	n/a	$11,270	$13,213
Net additions	32	64	113	176	136	207
Ending deployed units	214	278	391	567	703	910

EVOLV TECHNOLOGY RECONCILIATION OF GAAP TO ADJSUTED GROSS PROFIT AND GAAP OPERATING INCOME TO ADJUSTED OPERATING INCOME (In thousands) (Unaudited)
	Three Months Ended March 31,
	2022			2021
Revenue	$	8,715		$	3,999
Cost of revenue		7,089			2,951
Gross Profit		1,626			1,048
Stock-based compensation		60			5
Adjusted Gross Profit	$	1,686		$	1,053
Gross Margin %		18.7%			26.2%
Adjusted Gross Margin %		19.3%			26.3%
	Three Months Ended March 31,
	2022			2021
Operating income (loss) GAAP	$	(25,902)		$	(9,147)
Stock-based compensation		5,190			1,082
Restructuring expenses		324			-
Loss on impairment of lease equipment		96			-
Other one-time expenses		1,107			-
Adjusted Operating Income (loss)	$	(19,185)		$	(8,065)

EVOLV TECHNOLOGY RECONCILIATION OF GAAP NET INCOME TO ADJUSTED EBITDA (In thousands) (Unaudited)
	Three Months Ended March 31,
		2022				2021
Net income (loss)	$	(14,551	)		$	(13,755	)
Depreciation & Amortization		948				452
Stock-based compensation		5,190				1,082
Interest and other income (expense)		(67	)			2,447
Loss on disposal of property & equipment		-				-
Loss on extinguishment of debt		-				-
Change in fair value of derivative liability		-				1,425
Change in fair value of contingent earn-out liability		(4,226	)			-
Change in fair value of contingently issuable common stock liability		(1,472	)			-
Change in fair value of public warrant liability		(5,586	)			-
Change in fair value of common stock warrant liability		-				736
Restructuring expenses		324				-
Loss on impairment of lease equipment		96				-
Other one-time expenses		1,107				-
Adjusted EBITDA	$	(18,237	)		$	(7,613	)

EVOLV TECHNOLOGY RECONCILIATION OF GAAP NET INCOME AND EARNINGS PER SHARE TO ADJUSTED EARNINGS AND EARNINGS PER SHARE (In thousands, except share and per share data) (Unaudited)
	Three Months Ended March 31,
		2022				2021
Net income (loss)	$	(14,551	)		$	(13,755	)
Stock-based compensation		5,190				1,082
Change in fair value of derivative liability		-				1,425
Change in fair value of contingent earn-out liability		(4,226	)			-
Change in fair value of contingently issuable common stock liability		(1,472	)			-
Change in fair value of public warrant liability		(5,586	)			-
Change in fair value of common stock warrant liability		-				736
Restructuring expenses		324				-
Loss on impairment of lease equipment		96				-
Other one-time expenses		1,107				-
Adjusted earnings (loss)	$	(19,118	)		$	(10,512	)
Weighted average common shares outstanding – basic and diluted		142,878,406				10,443,323
Adjusted EPS	$	(0.13	)		$	(1.01	)

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220510006519/en/

Investor Relations:

Brian Norris

Vice President of Investor Relations

bnorris@evolvtechnology.com

Source: Evolv Technology

FAQ

What were Evolv Technology's Q1 2022 earnings results?

Evolv Technology reported Q1 2022 revenue of $8.7 million, a 118% increase year-over-year.

What is Evolv Technology's guidance for total revenue in 2022?

Evolv Technology reaffirmed its total revenue guidance for 2022 at $29-$31 million.

How much did Evolv Technology's Annual Recurring Revenue (ARR) grow in Q1 2022?

Evolv Technology's ARR grew by 207% to $16.6 million in Q1 2022.

What was Evolv Technology's net loss for Q1 2022?

Evolv Technology reported a net loss of $14.6 million for Q1 2022.

How many Evolv Express subscriptions were active at the end of Q1 2022?

Evolv Technology had 910 Evolv Express subscriptions active at the end of Q1 2022, a 227% increase year-over-year.